48,830
edits
Line 3: | Line 3: | ||
==Utility== | ==Utility== | ||
Use of immunohistochemistry:<Ref name=Ref_PCBoD8_175>{{Ref PCPBoD8|175}}</ref> | Use of immunohistochemistry:<Ref name=Ref_PCBoD8_175>{{Ref PCPBoD8|175}}</ref> | ||
#Unknown primary tumours. | #[[Unknown primary tumours]]. | ||
#Poorly differentiated tumours. | #Poorly differentiated tumours. | ||
#Prognostic markers, e.g. ERBB2 (HER2). | #Prognostic markers, e.g. ERBB2 (HER2). |
edits